Survival outcomes for patients with AJCC ... 39.6% ± 0.8% for T4N1. In patients with T1-2N2 versus T3N2/T4N2 cancers, 5-year observed survival was 61.5% ± 2.6% (T1-2N2) versus 38.1% ± 0.6% for T3N2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback